Ephedra alkaloids and brief relapse in EMDR-treated obsessive compulsive disorder.
Corrigan
F M
FM
Jennett
J
J
D000328:Adult; D003887:Desensitization, Psychologic; D029789:Ephedra / Q000009:adverse effects*; D005133:Eye Movements; D005260:Female; D016666:Fluvoxamine / Q000627:therapeutic use*; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000139:chemically induced* / Q000188:drug therapy*; D008517:Phytotherapy / Q000009:adverse effects*; D028321:Plant Preparations / Q000009:adverse effects* / Q000627:therapeutic use; D012008:Recurrence; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D013313:Stress Disorders, Post-Traumatic; D015431:Weight Loss
D016666:Fluvoxamine; D028321:Plant Preparations; D017367:Selective Serotonin Reuptake Inhibitors